Gujarat Themis Biosyn has informed that the Board of Directors at its meeting held today, has considered and approved declaration of an Interim Dividend for the Financial Year 2022-23 of Rs 4.40 (Rupees Four and forty paise only) per equity share having face value of Rs 5; 88% aggregating to Rs 6,39,26,289 (Rupees Six Crore Thirty Nine lakhs twenty six thousand two hundred eighty nine only); The Record date for the same is 2nd December, 2022. This is taken as compliance under the Listing Regulations.
The above information is a part of company’s filings submitted to BSE.
